A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly SchedulesBoddy, A. V. · Clinical Cancer Research · 2005

Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumorsMukai, Hirofumi; Kato, Ken; Esaki, Taito; Ohsumi, Shouzou; Hozomi, Yasuo; Matsubara, Nobuaki; Hamaguchi, Tetsuya; Matsumura, Yasuhiro; Goda, Rika; Hirai, Takayuki; Nambu, Yoshihiro · Investigational New Drugs · 2016

Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancerM.B Polee; J Verweij; P.D Siersema; H.W Tilanus; T.A.W Splinter; G Stoter; A Van der Gaast · 2002

The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen : A Phase I–II study of paclitaxel, cisplatin, and vinorelbineJacob J. Lokich; Norwood Anderson; Murray Bern; Frank Coco; Edward Dow · 1999

Real-time pharmacokinetics guiding clinical decisions: phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumoursO. Soepenberg; A. Sparreboom; M.J.A. de Jonge; A.S.Th. Planting; G. de Heus; W.J. Loos; C.M. Hartman; C. Bowden; J. Verweij · 2004

Phase I Study of a Weekly Schedule of Fixed-Dose Paclitaxel and Escalating Doses of Cisplatin for Recurrent or Unresectable Gastric Cancer in JapanTakahashi, Naoto; Kashiwagi, H; Iwabuchi, S; Yamazaki, Y; Yanaga, K · American Journal of Clinical Oncology · 2005

872 - Phase I–II study of simultaneous radiotherapy and paclitaxel (taxol) in a twice a week (TIW) schedule for recurrent squamous cell carcinomas of the head and neck (SCCHN)A. Becker; Th. Büchele; A. Sandner; Ch. Weigel; Ch. Schöber; H.-J. Schmoll · 1997